A Study of the Safety and Effectiveness of Levofloxacin Compared With Cefaclor in the Treatment of Adults With Chronic Bronchitis Experiencing Rapid Onset of Worsening of Symptoms Caused by Bacteria

NCT00257140 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

367

Enrollment

INDUSTRY

Sponsor class

Conditions

Bronchitis
Bronchitis, Chronic

Interventions

DRUG: levofloxacin

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Collaborators

[object Object]